Alvaro F. Guillem, Ph.D.

Interim Chief Executive Officer

Notable previous role and experience:
• President & CEO of ZS Pharma (sold to AstraZeneca for $2.7B)
• VP, Adams Respiratory Therapeutics (sold to Reckitt Benckiser for $2.3B)
• Senior roles at Wyeth and Boehringer Ingelheim
• PhD in Chemistry from Virginia Commonwealth University

Back to Home